Unituxin and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Unituxin (dinutuximab), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Acetaminophen, and have Neuroblastoma.

The phase IV clinical study analyzes which people have Weight increased when taking Unituxin. It is created by eHealthMe based on reports of 489 people who have side effects when taking Unituxin from the FDA, and is updated regularly.

What is Unituxin?

Unituxin has active ingredients of dinutuximab. eHealthMe is studying from 489 Unituxin users. Check the latest studies of Unituxin.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,953 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 21, 2026

489 people reported to have side effects when taking Unituxin.
Among them, 40 people (8.18%) have Weight increased.

Among these 40 people:

How long have people been on Unituxin when they have Weight increased? *

What is the gender of people who have Weight increased when taking Unituxin? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Weight increased when taking Unituxin? *

What are other drugs people take besides Unituxin? *

Acetaminophen: 16 people, 40.00%
Hydroxyzine: 10 people, 25.00%
Furosemide: 9 people, 22.50%
Morphine: 8 people, 20.00%
Lasix: 5 people, 12.50%
Hydroxyzine Hydrochloride: 5 people, 12.50%
Famotidine: 4 people, 10.00%
Magnesium Oxide: 3 people, 7.50%
Paracetamol: 3 people, 7.50%
Locoid: 3 people, 7.50%

What are other side effects people have besides Weight increased? *

Fever: 39 people, 97.50%
Abdominal Pain: 23 people, 57.50%
Aspartate Aminotransferase Increased: 23 people, 57.50%
Alanine Aminotransferase Increased: 21 people, 52.50%
Thrombocytopenia (decrease of platelets in blood): 21 people, 52.50%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 21 people, 52.50%
Oedema (fluid collection in tissue): 20 people, 50.00%
Pain In Extremity: 20 people, 50.00%
C-Reactive Protein Increased: 18 people, 45.00%
Nausea And Vomiting: 18 people, 45.00%

What are the existing conditions these people have? *

Neuroblastoma (a cancer that forms in your nerve tissue): 37 people, 92.50%
Pain: 8 people, 20.00%
Oedema (fluid collection in tissue): 5 people, 12.50%
Abdominal Pain: 3 people, 7.50%
Fever: 3 people, 7.50%
Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 3 people, 7.50%
Diarrhea: 3 people, 7.50%
Back Pain: 2 people, 5.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 5.00%
Iron Overload: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Unituxin and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Unituxin:

Unituxin (489 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

Browse all side effects of Unituxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,953 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dinutuximab (the active ingredients of Unituxin) and Unituxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.